Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyo…
$2.61+5.89%
报价 2026-11-06
市值
$211.7M
EV
$240.7M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -38.1%
$1.39$4.21
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ELDNEledon Pharmaceuticals, Inc. | $211.7M | +5.9% | -100.0% | 0% | – | – | – | |
| ACHVAchieve Life Sciences, Inc. | $691.5M | +5.4% | – | 0% | – | – | – | |
| PBYIPuma Biotechnology, Inc. | $425.9M | -15.6% | +0.2% | 74.5% | 10.1x | 5.4x | 10.1x | |
| EDITEditas Medicine, Inc. | $394.7M | +0.8% | -41.9% | 56.9% | – | – | – | |
| ALLOAllogene Therapeutics, Inc. | $359.3M | -4.6% | – | 0% | – | – | – | |
| AVIRAtea Pharmaceuticals, Inc. | $345.7M | +2.1% | -19.7% | 0% | – | – | – | |
| ABEOAbeona Therapeutics Inc. | $238.5M | +6.6% | +1241.7% | 26.3% | 3.3x | – | – | |
| VNDAVanda Pharmaceuticals Inc. | $231M | +6.4% | +20.3% | 93.2% | – | – | – | |
| TRDAEntrada Therapeutics, Inc. | $190.4M | +7.5% | -36.1% | -754.7% | – | – | – | |
| 同行中位数 | – | – | -9.7% | 13.2% | 6.7x | 5.4x | 10.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。